Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Fibrosis, characterized by excessive extracellular matrix accumulation, is a common feature of many connective tissue diseases, notably scleroderma (systemic sclerosis). Experimental studies suggest that a complex network of intercellular interactions involving endothelial cells, epithelial cells, fibroblasts and immune cells, using an array of molecular mediators, drives the pathogenic events that lead to fibrosis. Transforming growth factor-beta and endothelin-1, which are part of a cytokine hierarchy with connective tissue growth factor, are key mediators of fibrogenesis and are primarily responsible for the differentiation of fibroblasts toward a myofibroblast phenotype. The tight skin mouse (Tsk-1) model of cutaneous fibrosis suggests that numerous other genes may also be important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been shown that persistent inflammation results in up-regulation of various proinflammatory cytokines and chemokines, which further induce the expression of growth factors (e.g., PDGF, TGF-β1, activin), stimulating fibroblast proliferation, their differentiation into myofibroblasts, and production of ECM in a variety of fibrotic diseases, including hypertrophic scars and keloids [259–261].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [259]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290 · cited 1×
“These cells, which are characterized by the presence of stress fibres containing αsmooth muscle actin (SMA), play a pivotal role in ECM deposition and wound contraction during the normal wound healing process [26].”
BackgroundRegulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629 · cited 1×
“Importantly, it also acts as a switch, turning on the production of other growth factors such as vascular endothelial growth factor, which then signal to endothelial cells [28,29].”
BackgroundThe endothelin system in pulmonary arterial hypertension
GALIE, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.026 · Cited by 515 · cited 2×
“Cardiovascular Research © Elsevier 2004 [4].”
BackgroundConnective Tissue Growth Factor: What's in a Name?
Moussad, E. E.-D. A., & Brigstock, D. R. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3059 · Cited by 470 · cited 1×
“CTGF, a cytokine that stimulates fibroblast growth and upregulation of collagen and fibronectin in vitro [11], is a difficult molecule to study experimentally, but there is evidence to suggest it mediates certain effects of TGF-β and ET-1 on ECM production [12,13].”
BackgroundHocher, B., Thöne-Reineke, C., Rohmeiss, P., Schmager, F., Slowinski, T., Burst, V, Siegmund, F., Quertermous, T., Bauer, C., Neumayer, H. H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119297 · Cited by 409 · cited 2×
“In this model, pronounced renal fibrosis was associated with an age-dependent decrease in glomerular filtration that culminated in fatal kidney disease [ 15 ].”
BackgroundDistler, J. H. W., Jüngel, A., Huber, L. C., Schulze‐Horsel, U., Zwerina, J., Gay, R. E., Michel, B. A., Hauser, T., Schett, G., Gay, S., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22314 · Cited by 383 · cited 1×
“For example, using this model, the protein kinase inhibitor imatinib mesylate (a selective, dual inhibitor of TGF-β and platelet-derived growth factor) was shown to have potent antifibrotic effects [22], although perhaps not in later stages of fibrosis [23].”
MethodA tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation.
Siracusa, L. D., McGrath, R., Ma, Q., Moskow, J. J., Manne, J., Christner, P. J., Buchberg, A. M., & Jimenez, S. A. (1996) · Genome Research · doi:10.1101/gr.6.4.300 · Cited by 293 · cited 1×
“and the major component of microfibrils, found with or without associated elastin [17].”
BackgroundPulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice
Hocher, B., Schwarz, A., Fagan, K. A., Thöne-Reineke, C., El-Hag, K., Kusserow, H., Elitok, S., Bauer, C., Neumayer, H.-H., Rodman, D. M., et al. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.1.4030 · Cited by 219 · cited 1×
“Other work in a transgenic mouse model has shown ET-1 over-expression to lead to the recruitment of inflammatory cells in respiratory tissues and subsequent development of progressive pulmonary fibrosis [16].”
BackgroundParacrine regulation of keratinocyte proliferation and differentiation
Werner, S., & Smola, H. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01955-9 · Cited by 184 · cited 1×
“Importantly, it also acts as a switch, turning on the production of other growth factors such as vascular endothelial growth factor, which then signal to endothelial cells [28,29].”
BackgroundMechanisms and consequences of fibrosis in systemic sclerosis
Denton, C. P., Black, C. M., & Abraham, D. J. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0115 · Cited by 181 · cited 1×
“also internal organs such as lungs and kidneys, leading to organ dysfunction and failure [1].”
BackgroundSelf-citation
Cited by
Transition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 641
Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders
Piera-Velazquez, S., Li, Z., & Jimenez, S. A. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.001 · Cited by 580
Keloids: The paradigm of skin fibrosis — Pathomechanisms and treatment
Andrews, J. P., Marttala, J., Macarak, E., Rosenbloom, J., & Uitto, J. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.01.013 · Cited by 433
“While fibroblasts play a central role leading to ECM overproduction, epithelial-mesenchymal cross-talk has also been implicated between keratinocytes and dermal fibroblasts [24,25].”
Cell-Extracellular Matrix Interactions in Normal and Diseased Skin
Watt, F. M., & Fujiwara, H. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005124 · Cited by 384
“Fibrosis is a hallmark of many connective tissue diseases, including scleroderma and systemic sclerosis (reviewed by Ihn 2005; Krieg et al. 2007; Olson and Soriano 2009).”
Background
Metadata
- Authors
- Krieg, T., Abraham, D., & Lafyatis, R.
- Affiliations
- University of Cologne (DE)
- The Royal Free Hospital (GB)
- Boston University (US)
- Corresponding author
- Krieg, Thomas
- Venue
- Arthritis Research & Therapy
- Published
- 2007
- Volume
- 9
- Issue
- Suppl 2
- Pages
- S4
- ISSN
- 1478-6354 (ISSN-L)
- PMC
- PMC2072888
- OpenAlex
- W2145999911
- Cited by
- 151
- References
- 35
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 9 · 2019: 5 · 2018: 11 · 2017: 10 · 2016: 13 · 2015: 8 · 2014: 5 · 2013: 10 · 2012: 12
- Type
- conference abstract
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Arthritis Research & Therapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- OpenBU (Boston University) (submittedVersion)
- Funders
- Actelion Pharmaceuticals
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- fibrosis, connective tissue diseases, systemic sclerosis, myofibroblasts, extracellular matrix accumulation, TGF-beta, endothelin-1, connective tissue growth factor, fibroblast differentiation, tight-skin mouse, skin fibrosis, endothelial cells, immune cells
- MeSH terms
- Animals, Cell Communication, Connective Tissue Diseases, Epithelial Cells, Fibroblasts, Fibrosis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions. https://app.cochat.ai/papers/10.1186/ar2188
- The paper
- Krieg, T., Abraham, D., & Lafyatis, R. (2007). Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions. Arthritis Research & Therapy. https://doi.org/10.1186/ar2188
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.